Author

R. kolb

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

K. K. Ahmed· 2 shared N. Borcherding· 2 shared W. Zhang· 2 shared A. P. Voigt· 1 shared A. Vishwakarma· 1 shared E. Cho· 1 shared G. Pandey· 1 shared H. Kates· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. K. Ahmed

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The distinct roles of MSH2 and MLH1 in basal-like breast cancer and immune modulation

T. I. Tithi, J. Mo, N. Borcherding, S. Jo, E. Cho, K. E. Cash, M. Honda, L. Wang, K. K. Ahmed, K. Shirlekar, L. Chen, R. Weigel, H. Kates, K. Gibson-Corley, M. Spies, , W. Zhang

This study identifies distinct roles of MSH2 and MLH1 in basal-like breast cancer, showing MSH2 promotes metastasis while MLH1 enhances it, and reveals MSH2's role in immune modulation through IFNAR1 regulation.

bioRxiv · Jul 20, 2023 · PreprintCancer Biology

Transcriptional heterogeneity in cancer-associated regulatory T cells is predictive of survival.

N. Borcherding, K. K. Ahmed, A. P. Voigt, A. Vishwakarma, R. Kolb, P. Kluz, G. Pandey, K. N. Gibson-Corley, J. Klesney-Tait, Y. Zhu, J. Lu, J. Lu, X. Huang, J. Cheng, S. G. Zheng, , W. Zhang

The paper identifies transcriptional subtypes of tumor-infiltrating regulatory T cells and shows that a CD177+ subset predicts poorer survival in renal clear cell carcinoma and other cancers.

bioRxiv · Nov 26, 2018 · PreprintCancer Biology